Mus musculus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1061818 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR27448818_1.fastq.gz | Fastqsanger.gz | |||
| SRR27448818_2.fastq.gz | Fastqsanger.gz | |||
| SRR27448819_1.fastq.gz | Fastqsanger.gz | |||
| SRR27448819_2.fastq.gz | Fastqsanger.gz | |||
| SRR27448820_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 36 |
Similar Datasets
Project description:A fundamental objective of genomics is to track variations in gene expression programs that define cell state progression during development, differentiation, and response to stimuli. While metabolic RNA labeling-based single-cell RNA sequencing offers insights into temporal biological processes, its limited applicability to in vitro models challenges the study of in vivo gene expression dynamics. Herein, we introduce Dyna-vivo-seq, a strategy that enables time-resolved dynamic transcription profiling in vivo at the single-cell level by simultaneously examining new and old RNAs. Leveraging Dyna-vivo-seq, we characterized the heterogeneity of RNA dynamics and quantified turnover rates of 21, 231 genes in 24, 237 single cells. The new RNAs can offer an additional dimension to facilitate the discernment of cellular heterogeneity. Based on new RNAs, we discerned two distinct high and low metabolic labeling populations among proximal tubular (PT) cells. Leveraging the enhanced sensitivity of new RNA-based analysis, we identified 90 rapidly responded transcription factors (TFs) and explored the heterogeneous response of PT cells for the AKI, highlighting that PT cells with high RNA metabolic activity exhibit heightened susceptibility to injury. Dyna-vivo-seq has introduced a temporal dimension to traditional otherwise static measurements in vivo, providing a powerful tool to the characterization of dynamic transcriptome changes at single cell leveles in living organisms and holding great promise for a wide range of biomedical applications.
2024-01-23 | GSE253836 | GEO
Project description:Single-cell (sc)RNA-seq, together with RNA velocity and metabolic labeling, reveals cellular states and transitions at unprecedented resolution. Fully exploiting these data, however, requires kinetic models capable of unveiling governing regulatory functions. Here, we introduce an analytical framework dynamo, which infers absolute RNA velocity, reconstructs continuous vector fields that predict cell fates, employs differential geometry to extract underlying regulations, and ultimately predicts optimal reprogramming paths and perturbation outcomes. We highlight dynamo’s power to overcome fundamental limitations of conventional splicing-based RNA velocity analyses to enable accurate velocity estimations on a metabolically labeled human hematopoiesis scRNA-seq dataset. Furthermore, differential geometry analyses reveal mechanisms driving early megakaryocyte appearance and elucidate asymmetrical regulation within the PU.1-GATA1 circuit. Leveraging the least-action-path method, dynamo accurately predicts drivers of numerous hematopoietic transitions. Finally, in silico perturbations predict cell-fate diversions induced by gene perturbations. Dynamo, thus, represents an important step in advancing quantitative and predictive theories of cell-state transitions.
2022-02-02 | GSE193517 | GEO
Project description:Single-cell RNA sequencing reveals the transcriptional heterogeneity of single cells, but offers static snapshots of gene expression and fails to reveal the temporal dynamics of transcription. Herein, we develop Well-TEMP-seq, a high-throughput, cost-effective, accurate, and efficient method for massively parallel profiling the time-resolved dynamics of single-cell gene expression. Well-TEMP-seq combines metabolic RNA labeling with our recently developed microwell-based single-cell RNA sequencing method (Well-Paired-seq) to distinguish newly transcribed RNAs marked by T-to-C substitutions from pre-existing RNAs in each of thousands of single cells. We further apply Well-TEMP-seq to profiling the dynamics of gene expression of colorectal cancer cells exposed to low-dose of 5-AZA-CdR, a clinically used DNA-demethylating anti-tumor drug. Well-TEMP-seq also for the first time reveals the activation of interferon responsive genes by 5-AZA-CdR induced viral mimicry in the first three days after treatment. Well-TEMP-seq will be broadly applicable to unveil the dynamics of single-cell gene expression in diverse biological processes.
2022-02-01 | GSE194357 | GEO
Project description:In order to distinguish transcription changes from RNA modification and post transcription changed, nascent RNA seq via metabolic labeling of freshly synthesized RNA was carried out using 4sU labeling/biotin purification.
2019-03-27 | GSE113861 | GEO
Project description:Understanding the molecular mechanisms of spatio-temporal gene expression is crucial for elucidating the dynamic processes that maintain tissue integrity, regulate cellular states, and drive biological responses. Despite recent advances in spatial transcriptomics, most approaches lack temporal resolution, limiting insights into dynamic gene expression. Here, we present DynaST-seq, an advanced spatio-temporal transcriptomics technology that integrates metabolic RNA labeling with spatial transcriptomics, enabling high-resolution, transcriptome-wide profiling of RNA dynamics across space and time. The high-resolution capabilities of DynaST-seq reveal finer tissue structures, such as vasculature, and provide a detailed understanding of cellular composition and RNA dynamics at the single-cell level. With its high sensitivity to newly synthesized RNA, DynaST-seq facilitates early detection of cellular responses to injury, offering detailed insights into processes such as oxidative stress, mitochondrial dysfunction, lipid dysmetabolism, and inflammatory responses during acute kidney injury (AKI). Our analysis identified rapidly responding transcription factors regulating AKI-related biological processes and uncovered enhanced interactions in regions of elevated RNA metabolic activity. This approach offers novel insights into tissue architecture, cellular behavior, and the regulatory networks underlying dynamic biological processes, holding a great promise for a wide range of biomedical applications.
2025-07-01 | GSE290361 | GEO
Project description:Poly(A) tails protect RNAs from degradation and deadenylation rates determine RNA stability. Deadenylation has mostly been investigated within the cytoplasm and the dynamics of poly(A) tail length after transcription are not well understood. Combining long-read sequencing with metabolic labeling and cell fractionations, we investigate deadenylation dynamics of newly synthesized poly(A) tails in vitro and in vivo. We report evidence for genome-wide synthesis of poly(A) tails longer than 200 nt which are enriched upon splicing inhibition. Metabolic labeling reveals rapid deadenylation of poly(A) tails within minutes after transcription. Fractionation experiments show that initial deadenylation is a nuclear process, and that different classes of transcripts, including long noncoding RNAs, have distinctive nuclear poly(A) tail lengths. Modelling deadenylation dynamics predicts that deadenylation in the nucleus is by an order of magnitude faster than in the cytoplasm. In summary, we suggest nuclear deadenylation as a novel regulatory layer which may determine stability and abundance before mRNAs reach the cytoplasm.
2023-01-07 | GSE188539 | GEO
Project description:Benchmarking Metabolic RNA Labeling Techniques for High-Throughput Single-Cell RNA Sequencing (PRJCA037071)
| PRJDB34773 | ENA
Project description:Dendritic cell (DC) vaccine was among the first FDA-approved cancer immunotherapies, but has been limited by the modest cytotoxic T lymphocyte (CTL) response and therapeutic efficacy. Here we report a facile metabolic labeling approach that enables targeted modulation of adoptively transferred DCs for developing enhanced DC vaccines. We show that metabolic glycan labeling can reduce the membrane mobility of DCs, which activates DCs and improves the antigen presentation and subsequent T cell priming property of DCs. Metabolic glycan labeling itself can enhance the antitumor efficacy of DC vaccines. In addition, the cell-surface chemical tags (e.g., azido groups) introduced via metabolic glycan labeling also enable in vivo conjugation of cytokines onto adoptively transferred DCs, which further enhances CTL response and antitumor efficacy. Our DC labeling and targeting technology provides a new strategy to improve the therapeutic efficacy of DC vaccines, with minimal interference upon the clinical manufacturing process.
2023-07-22 | GSE238016 | GEO
Project description:The capability to spatially explore RNA biology in formalin-fixed paraffin-embedded (FFPE) tissues holds transformative potential for histopathology research. Here, we present pathology-compatible deterministic barcoding in tissue (Patho-DBiT) by combining in situ polyadenylation and computational innovation for spatial whole transcriptome sequencing, tailored to probe the diverse RNA species in clinically archived FFPE samples. It permits spatial co-profiling of gene expression and RNA processing, unveiling region-specific splicing isoforms, and high-sensitivity transcriptomic mapping of clinical tumor FFPE tissues stored for five years. Furthermore, genome-wide single nucleotide RNA variants can be captured to distinguish malignant subclones from non-malignant cells in human lymphomas. Patho-DBiT also maps microRNA regulatory networks and RNA splicing dynamics, decoding their roles in spatial tumorigenesis. Cellular-level Patho-DBiT dissects the spatiotemporal cellular dynamics driving tumor clonal architecture and progression. Patho-DBiT stands poised as a valuable platform to unravel rich RNA biology in FFPE tissues to aid in clinical pathology evaluation.
2024-08-12 | GSE274641 | GEO
Project description:Gene expression profiling by high-throughput sequencing reveals qualitative and quantitative changes in RNA species at steady-state but obscures the intracellular dynamics of RNA transcription, processing and decay. We developed thiol(SH)-linked alkylation for the metabolic sequencing of RNA (SLAM-seq), an orthogonal chemistry-based epitranscriptomics-sequencing technology that uncovers 4-thiouridine (s4U)-incorporation in RNA species at single-nucleotide resolution. In combination with well-established metabolic RNA labeling protocols and coupled to standard, low-input, high-throughput RNA sequencing methods, SLAM-seq enables rapid access to RNA polymerase II-dependent gene expression dynamics in the context of total RNA. When applied to mouse embryonic stem cells, SLAM-seq provides global and transcript-specific insights into pluripotency-associated gene expression. We validated the method by showing that the RNA-polymerase II-dependent transcriptional output scales with Oct4/Sox2/Nanog-defined enhancer activity; and provides quantitative and mechanistic evidence for transcript-specific RNA turnover mediated by post-transcriptional gene regulatory pathways initiated by microRNAs and N6-methyladenosine. SLAM-seq facilitates the dissection of fundamental mechanisms that control gene expression in an accessible, cost-effective, and scalable manner.
2017-09-23 | GSE99977 | GEO